Restated financial statements available on World Help website

As was promised, this morning World Help released restated financial statements for their 2011 and 2010 fiscal years.  A clean audit opinion is attached.

You can see it available on this page of their website. You can click directly to the report here.

The financial statements contain an emphasis of matter paragraph in the opinion, revised income and expense amounts on the statement of activity, and a new note 11 describing the revision to the financial statements.

(more…)

Amended 990 is available on World Help web site

As was promised to several reporters this week, World Help has made their amended 990 available on their website this evening. You can see the link on the website here and click directly to the 990 here.

As they have said publicly, the revised revenue for 2011 is $104M.  The 2010 revenue has been restated downward from $125.1M to $64.1M.

Here is a summary of the changes.

(more…)

Two donors to World Help say they didn’t give, in addition to World Help saying it overstated revenue

That’s the very short version of the report from Doug Donovan and Caroline Preston at The Chronicle of PhilanthropyCharity Lowers Revenue Figure by $135-Million.

World Help will reduce 2011 revenue from $239.3M to $104.1M, a drop of $135.2M.  They will also be revising their 2010 and 2009 tax filings according to the article.

Most of that drop is due to one transaction, a donation from Direct Relief International.  It looks to me like revenue from that contribution will drop from $100.1M to $3.3M, a decline of $96.8M.

Two donors say they didn’t donate

More big news in the article is that two donors say they didn’t send large volumes of GIK to World Help.  From the article: (more…)

World Help says they overstated revenue by half of the audited amount

That is according to an article by William Barrett in Forbes – Big Charity Admits Wildly Overstating Donated Goods

World Help disclosed to Mr. Barrett that revenue for 2011 was overstated by about $135M of the reported $239M.

The core issue is that for one transaction, a donation of medical goods from a California-based NPO, World Help alleges that the amounts on the paperwork were altered when provided to World Help. Check out the full article for more details.

(more…)

It’s complicated, Africa version

Our perceptions of what’s taking place in Africa fluctuate between wild optimism and hopeless despair, cycling back and forth depending on this year’s headlines. Things are actually far more complicated, showing lots of reasons for some optimism simultaneous with indications of hard days now and in the future.

That’s what I learned from Walter Russell Mead’s post, Agony in The Congo.

(Why this post on that essay?  We need to understand the complexities of the world around us if we want to actually change the world.)

(more…)

Do you own your data that is stored in the cloud? If your cloud provider gets in a jam with the government, can you get your data back?

Those are two extremely serious questions that everyone who is storing data in the cloud should start asking.

What would happen to your business or ministry or hobby if the feds seized the server of your cloud provider and you had to fight in court to get your data back?

How would you cope with this situation:

Megaupload is a cloud provider who stands accused of essentially being a storehouse of pirated videos. Their servers were seized by the federal government. That means the data of every user was also seized.

(more…)

To get a nonprofit rate for software, try asking your vendor

If you want to get the bargain prices on software that are offered to nonprofit organizations by two outfits that specialize in doing so, try asking your computer vendor for the same deals.

My church recently ordered several computers from Dell. I told our tech guy doing the ordering about Consistent Computer Bargains, who has great prices for NPOs on lots of software.

He did more research and found that those same prices are offered on specific SKUs for Microsoft software.

We asked the Dell representative about those prices. Said representative hadn’t heard of that, and after checking with a supervisor to learn it was available, included those special prices in the bid.

(more…)

An open letter to the CPAs who audit R&D charities receiving GIK meds

Dear colleagues:

If you would like some background on the GIK issues, please read my open letter to your clients.

The accounting is problematic for donated pharmaceuticals that you have been auditing for the last few years. 

If you have a budget of 100 or 300 hours, it might be wise to allocate a few hours to read beyond AICPA risk alerts and Accord position papers. You can browse my blog for  discussions, which contain links to other resources that also discuss the accounting and valuation issues.

It is my considered opinion that many of the valuations are not supportable under GAAP.  The timing of SFAS 157 isn’t the issue. 

The amount of scrutiny on your client’s valuation methodologies is high and increasing.

(more…)

An open letter to the evangelical nonprofit community receiving GIK meds

Dear brothers and sisters in Christ:

The accounting for donated pharmaceuticals has been poor for a number of years. 

The valuations are not supportable by accounting rules either before or after SFAS 157 went into effect. 

Paying a handling fee roughly comparable to available open market price lists sure makes the donations look like purchases.  Fair value does not involve using a valuation in the U.S. for meds that can’t be legally sold here.  A reference book that is known to not reflect actual market prices is not a reasonable basis for determining fair value.  

People outside the evangelical NPO community are starting to notice.

(more…)

Three questions for valuing donated medicine plus a bonus question

There is a big issue in the NPO community now about how to value donated pharmaceuticals. To help the discussion along, I have three questions to help charities and their auditors process through what is the appropriate methodology.

I will pose three questions and ponder them for a moment. Each of the questions is really worth a long, extended conversation.

Should the medicine be valued at what was paid in the course of acquiring it or is there a bargain purchase?

(more…)